Picture of Allergy Therapeutics logo

AGY Allergy Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Allergy Therapeutics FY Revenue Fell 16% To 61.0 Million Stg

Sept 27 (Reuters) - Allergy Therapeutics PLC  AGY.L :
    * FY REVENUE FELL 16 PERCENT TO 61.0 MILLION STG
    * FY REVENUE OF £61.0M (2022: £72.8M) FROM COMMERCIAL
PORTFOLIO
    * SUBJECT TO TIMING AND VOLUME OF SALES IN QUARTER TO DEC
2023,
EXPECTS ADDITIONAL FUNDING TO BE REQUIRED FROM AROUND NOV 2023
ONWARDS
    * PIVOTAL PHASE III GRASS G306 MATA MPL TRIALUNDERWAY AND ON
TRACK
TO REPORTINTERIM TRIAL RESULTS IN, OR AROUND, NOVEMBER 2023

Source text for Eikon:  ID:nRSa7517Na 
Further company coverage:  AGY.L 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Allergy Therapeutics

See all news